NCT00216684View on ClinicalTrials.gov

Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics

PHASE3CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

September 30, 2006

Conditions
Pain, Intractable
Interventions
DRUG

fentanyl

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY

NCT00216684 - Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics | Biotech Hunter | Biotech Hunter